FTSE MIB
25.974,58 -507,63 (-1,92%) Dow Jones
32.105,24 -0,01 (-0,00%) Nasdaq
11.764,94 -22,46 (-0,19%) Nikkei 225
27.385,25 -34,36 (-0,13%) Petrolio
69,17 -0,79 (-1,13%) Bitcoin EUR
26.052,70 -545,27 (-2,05%)
XOMA Corporation (0M26.L)
| Chiusura precedente | 21,90 |
| Aperto | 0,00 |
| Denaro | 0,00 x N/D |
| Lettera | 0,00 x N/D |
| Min-Max giorno | 0,00 - 0,00 |
| Intervallo di 52 settimane | |
| Volume | |
| Media Volume | N/D |
| Capitalizzazione | N/D |
| Beta (5 anni mensile) | 0,89 |
| Rapporto PE (ttm) | 0,21 |
| EPS (ttm) | 1,00 |
| Prossima data utili | 03 mag 2023 - 08 mag 2023 |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
- GlobeNewswire
XOMA Declares Quarterly Preferred Stock Dividends
EMERYVILLE, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA’s Series A and Series B Cumulative Preferred Stock: Holders of the 8.625% Series A Cumulative Perpetual Preferred Stock (Nasdaq: XOMAP) shall receive a cash dividend equal to $0.53906 per share. Holders of depositary shares, each representing 1/1000 of a share of XOMA’s 8.375% Series
- GlobeNewswire
XOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy
2022 was the first year with cash receipts from a commercial asset since becoming a royalty aggregator Ebopiprant royalty and milestone license acquisition gives XOMA the potential to earn up to $378 million, net, in milestones plus mid-single digit to low teens royalties, net, from Organon The Executive Leadership Team additions of Owen Hughes and Brad Sitko bring royalty investment and portfolio management expertise to increase shareholder value from XOMA’s future acquisitions Royalty portfoli
- GlobeNewswire
XOMA to Present at 43rd Annual Cowen Health Care Conference
EMERYVILLE, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the Biotech Royalty Aggregator, announced today that Owen Hughes, Executive Chairman, and Brad Sitko, Chief Investment Officer, will be featured in a fireside chat at the 43rd Annual Cowen Health Care Conference on Tuesday, March 7, 2023, at 2:10 PM ET. The presentation can be accessed at https://bit.ly/3DmxDFH or by visiting the investor relations section of the Company’s website at www.xoma.com. A replay of
